课题基金 / 基金详情

Reconstitution and regulation of the blood-tissue barrier

Reconstitution and regulation of the blood-tissue barrier
血组织屏障的重建和调节
批准号:
14570196
负责人:
CHIBA Hideki
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

CHIBA Hideki的其他基金

相似基金

相关文献

中文摘要
翻译
环磷酸腺苷(CAMP)和丝裂原活化蛋白激酶(MAPK)调节内皮细胞紧密连接的屏障功能,尽管它们的靶点尚不清楚。我们发现cAMP可通过蛋白激酶A(PKA)依赖和非依赖途径诱导猪血脑屏障内皮细胞中claudin-5的磷酸化和基因表达。沿着这条线,我们在claudin-5的胞质内羧基末端结构域的大约207>处发现了一个假定的PKA的磷酸化位点。为了阐明该位点在调节内皮屏障功能中的生物学意义,我们建立了表达多西环素诱导的野生型Claudin-5及其突变体的大鼠肺内皮细胞(RLE),并将其替换为Ala。用多西环素处理这些细胞,或联合cAMP和/或PKA抑制剂H-89,我们发现野生型claudin-5的诱导足以重建泄漏的RLE细胞对菊糖(5 KDa)的细胞旁屏障,但不能重建甘露醇(182 KDa)的细胞旁屏障。我们还证明了cAMP激活的PKA靶向内皮细胞中Thr207>残基上的claudin-5。此外,我们发现claudin-5的Thr^和207是沿细胞边界增强claudin-5信号的关键,以及跨内皮细胞阻力的快速降低和基于claudin-5的内皮屏障的大小选择性松动。我们还在Claudin-1的203>附近发现了MAPK的一个有效的磷酸化位点,并确定了该位点的生物学作用。为此,我们建立了表达多西环素诱导的野生型claudin-1及其突变体的RLE细胞,并将Thr^<203>替换为Ala。我们的研究结果表明,Claudin-1的苏氨酸是增强基于Claudin-1的内皮屏障所必需的。RLE细胞中多西环素诱导的基因表达系统将有助于研究各种基因产物在血管内皮细胞中的功能。
英文摘要
Cyclic AMP(cAMP) and mitogen-activated protein kinase(MAPK) modulate the barrier function of tight junctions in endothelial cells, although their targets remain unknown. We showed that cAMP could induce phosphorylation and gene expression of claudin-5 in porcine blood-brain barrier endothelial cells via protein kinase A(PKA)-dependent and -independent pathways, respectively. Along this line, we identified a putative phosphorylation site for PKA at around Thr^<207> in the intracytoplasmic carboxyl terminal domain of claudin-5. To clarify the biological significance of this site in regulation of endothelial barrier functions, we established rat lung endothelial(RLE) cells expressing doxycycline-inducible wild-type claudin-5 and its mutant with substitution of Thr^<207> to Ala. Using these cells treated with doxycycline, or in combination with cAMP and/or the PKA inhibitor H-89, we showed that induction of wild-type claudin-5 was sufficient to reconstitute the paracellular barrier against inulin(5kDa), but not mannitol(182Da), in leaky RLE cells. We also demonstrated that cAMP-activated PKA targeted claudin-5 on the Thr^<207> residue in endothelial cells. Furthermore, we found that Thr^<207> of claudin-5 was critical for enhancement of claudin-5 signals along cell borders, as well as both rapid reduction in transendothelial resistance and size-selective loosening of the claudin-5-based endothelial barrier. We also recognized a potent phosphorylation site for MAPK at around Thr^<203> of claudin-1, and determined the biological role of the site. To this end, we generated RLE cells expressing doxycycline-inducible wild-type claudin-1 and its mutant with substitution of Thr^<203> to Ala. Our findings indicated that Thr^<203> of claudin-1 was required to enhance the claudin-1-based endothelial barrier. The doxycycline-inducible gene expression system in RLE cells will be useful for studying functions of various gene products in endothelial cells.
期刊论文(103)
专著(0)
科研奖励(0)
会议论文
Fujibe M et al.: "Thr203 of claudin-1, a putative phosphorylation site for MAP kinase is required to promote the barrier function of tight junctions."Exp Cell Res.. (in press).
Fujibe M 等人:“claudin-1 的 Thr203 是 MAP 激酶的假定磷酸化位点,需要促进紧密连接的屏障功能。”Exp Cell Res..(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kojima T et al.: "Cx32 formation and/or Cx32-mediated intracellular communication induce expression and function of tight junctions in hepatocytic cell line."Exp Cell Res.. 276. 40-51 (2002)
Kojima T 等人:“Cx32 形成和/或 Cx32 介导的细胞内通讯诱导肝细胞系中紧密连接的表达和功能。”Exp Cell Res.. 276. 40-51 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishizaki T et al.: "Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways."Exp Cell Res.. 290. 275-288 (2003)
Ishizaki T 等人:“环 AMP 通过依赖蛋白激酶 A 和不依赖蛋白激酶 A 的途径,诱导血脑屏障内皮细胞中claudin-5 免疫沉淀物的磷酸化和claudin-5 基因的表达。”Exp Cell Res.. 290。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kojima T et al.: "Inhibition of MAP-kinase activity moderates changes in expression and function of Cx32 but not claudin-1 during DNA synthesis in primary cultures of rat hepatocytes."Med Electron Microsc.. (in press).
Kojima T 等人:“在大鼠肝细胞原代培养物 DNA 合成过程中,MAP 激酶活性的抑制可调节 Cx32 表达和功能的变化,但不会调节claudin-1 的变化。”Med Electron Microsc..(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
31
    Development of a novel therapy targeting tight-junction protein occludin against hepatitis C
    • 批准号:
      23659187
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      CHIBA Hideki
    • 依托单位:
    Regulation of biological barrier and cell polarity formation
    • 批准号:
      19590398
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      CHIBA Hideki
    • 依托单位:
    国内基金
    海外基金
    “Claudin-2-RhoA-炎症小体”途径在I/R诱导的肾小管上皮细胞焦亡中的作用及调控机制
    • 批准号:
      2025JJ80074
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      汤进
    • 依托单位:
    转录因子ZEB1抑制claudin-7(CLDN7)促进乳腺癌EMT的机制及在临床中作为乳腺癌标记物的应用研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      沈峰清
    • 依托单位:
    放疗通过调控E3泛素连接酶促进Claudin-5降解介导抗体药物跨血脑/肿瘤屏障递送的机制研究
    • 批准号:
      MS25H220005
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      金厅
    • 依托单位:
    组蛋白乳酸化促使α/β水解酶结构域蛋白17(ABHD17)去棕榈酰化修饰Claudin18.2介导胃癌抗体偶联药物耐药的机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      崔越宏
    • 依托单位: